Cell cultured-derived adjuvanted influenza vaccine (AbbVie)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCell cultured-derived adjuvanted influenza vaccine (AbbVie)
Drug Alias NameCell-based adjuvanted seasonal influenza vaccine (Solvay/Petrovax)Grippol TC (cell-based adjuvanted seasonal vaccine, Abbott)Seasonal influenza vaccine (Solvay/Petrovax)Grippol NeoGrippol +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2011/11/25
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSolvayPetrovax Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A